Dr. Hönle AG (HNL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Dr. Hönle AG (HNL) has a cash flow conversion efficiency ratio of 0.038x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.96 Million ≈ $3.47 Million USD) by net assets (€77.03 Million ≈ $90.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Dr. Hönle AG - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Dr. Hönle AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read HNL current and long-term liabilities for a breakdown of total debt and financial obligations.
Dr. Hönle AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Dr. Hönle AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Power Metals Corp
V:PWM
|
-0.018x |
|
Sam Jung Pulp
KO:009770
|
0.010x |
|
Acrivon Therapeutics, Inc. Common Stock
NASDAQ:ACRV
|
-0.096x |
|
Mr Bricolage
PA:ALMRB
|
0.019x |
|
Plus Therapeutics Inc
NASDAQ:PSTV
|
-0.504x |
|
BranchOut Food Inc. Common Stock
NASDAQ:BOF
|
-0.347x |
|
Toivo Group Oyj
HE:TOIVO
|
-0.098x |
|
Voksel Electric Tbk
JK:VOKS
|
0.351x |
Annual Cash Flow Conversion Efficiency for Dr. Hönle AG (2014–2025)
The table below shows the annual cash flow conversion efficiency of Dr. Hönle AG from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see HNL market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | €77.03 Million ≈ $90.06 Million |
€4.99 Million ≈ $5.83 Million |
0.065x | -6.73% |
| 2024-09-30 | €79.69 Million ≈ $93.16 Million |
€5.53 Million ≈ $6.47 Million |
0.069x | +112.26% |
| 2023-09-30 | €96.13 Million ≈ $112.39 Million |
€3.14 Million ≈ $3.67 Million |
0.033x | +147.34% |
| 2022-09-30 | €107.24 Million ≈ $125.37 Million |
€-7.41 Million ≈ $-8.66 Million |
-0.069x | -779.14% |
| 2021-09-30 | €111.12 Million ≈ $129.91 Million |
€1.13 Million ≈ $1.32 Million |
0.010x | -83.60% |
| 2020-09-30 | €116.69 Million ≈ $136.42 Million |
€7.23 Million ≈ $8.46 Million |
0.062x | -66.99% |
| 2019-09-30 | €90.12 Million ≈ $105.36 Million |
€16.92 Million ≈ $19.79 Million |
0.188x | -32.34% |
| 2018-09-30 | €87.25 Million ≈ $102.00 Million |
€24.22 Million ≈ $28.31 Million |
0.278x | +194.37% |
| 2017-09-30 | €69.78 Million ≈ $81.58 Million |
€6.58 Million ≈ $7.69 Million |
0.094x | -32.66% |
| 2016-09-30 | €61.67 Million ≈ $72.10 Million |
€8.63 Million ≈ $10.09 Million |
0.140x | -12.08% |
| 2015-09-30 | €57.51 Million ≈ $67.24 Million |
€9.16 Million ≈ $10.71 Million |
0.159x | +5.68% |
| 2014-09-30 | €49.72 Million ≈ $58.13 Million |
€7.49 Million ≈ $8.76 Million |
0.151x | -- |
About Dr. Hönle AG
Hoenle AG develops, manufactures, and distributes industrial UV technologies and systems in Germany and internationally. It operates through three segments: Adhesive Systems, Curing, and Disinfection. The Adhesives Systems segment offers industrial adhesives, as well as supplies adhesive curing systems used for consumer electronics, automotive, optics and opto-electronics, and curing of adhesives… Read more